Cancer Prevention Pharmaceuticals, Inc. — Form D/A
Cancer Prevention Pharmaceuticals, Inc. of TUCSON, AZ, a company, filed a Form D amendment with the SEC on 2013-10-31. The offering totals $6.0M, of which $4.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-10-31
- Form: D/A
- Accession: 0001471002-13-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $4.3M
- Remaining: $1.7M
- Minimum investment: $20K
- Investors: 6
- Date of first sale: 2012-10-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-187203
Issuer
- Name: Cancer Prevention Pharmaceuticals, Inc.
- CIK: 0001471002
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1760 EAST RIVER ROAD, SUITE 250, TUCSON, AZ, 85718
- Phone: 520-908-7774
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Daniel W Donovan | Director | Tucson, AZ |
| Eugene W Gerner | Director | Tucson, AZ |
| Jeffrey E Jacob | Director | Tucson, AZ |
| Richard W Love | Director | Scottsdale, AZ |
| Frank W Meyskens | Director | Irvine, CA |
| Eugene W Gerner | Executive Officer | Tucson, AZ |
| Jeffrey E Jacob | Executive Officer | Tucson, AZ |
| Jon Saxe | Director | Mountain View, CA |
| Jeffrey Jacob | Director | New York, NY |
| Jeffrey Jacob | Executive Officer | New York, NY |
| Richard Love | Director | Scottsdale, AZ |
| John Saxe | Director | TUCSON, AZ |
| Eugene Gerner, Ph.D. | Director | TUCSON, AZ |
| Daniel Donovan | Director | TUCSON, AZ |
| Andrew Levitch | Executive Officer | SAN DIEGO, CA |
| Christopher Richied | Executive Officer | Tucson, AZ |
| Frank Meyskens | Director | Irine, CA |
Other filings by this issuer (8)
More